Q4 2025 Management View CEO Dan Bodner highlighted strong AI momentum, with annual recurring revenue (ARR) growth reaching 5% in Q4, surpassing prior guidance of 4%. He stated that ARR growth ...

Q1 2025 Management View CEO Chris Caldwell highlighted that Concentrix achieved year-over-year revenue and profitability growth above guidance in Q1 2025, driven by demand for consolidation ...

Plus Therapeutics (PSTV) reveals Q4 earnings on March 27. Key insights: EPS forecast -$0.50 (+88.2% Y/Y), revenue estimate $1.01M (-79.4% Y/Y).

Steelcase (SCS) delivered earnings and revenue surprises of 30% and 1.16%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?

Associated British Foods' (ASBFF) diversified business model provides resilience. See why I rate the stock a strong buy.

BRP reported Q4 results with a 19.7% revenue decrease year-over-year, beating expectations. Dividend declared. FY26 outlook ...

Although the revenue and EPS for Chewy (CHWY) give a sense of how its business performed in the quarter ended January 2025, it might be worth considering how some key metrics compare with Wall Street ...

Reports Q4 revenue $3.25B, consensus $3.2B. “Topline growth and profitability exceeded the high-end of our guidance ranges for both the fourth ...

As part of its growth strategy, DocuSign anticipates that by Q4 of fiscal year 2026, IAM will be responsible for a low double-digit percentage of overall business growth. This focus on technology ...